Bristol-Myers Squibb Co (NYSE:BMY)

57.74
Delayed Data
As of Oct 22
 -0.07 / -0.12%
Today’s Change
56.66
Today|||52-Week Range
69.75
-6.92%
Year-to-Date
Why Aurinia Pharmaceuticals Stock Is Blasting Higher Today
Oct 22 / MotleyFool.com - Paid Partner Content
Bristol Myers (BMY) Gets Positive CHMP Opinion for Zeposia in UC
Oct 18 / Zacks.com - Paid Partner Content
Here's Why Agenus Stock Is Getting Hammered Today
Oct 22 / MotleyFool.com - Paid Partner Content
2 Best Biotech Stocks to Buy Right Now
Oct 18 / MotleyFool.com - Paid Partner Content
What is in Store for Bristol-Myers (BMY) in Q3 Earnings?
Oct 22 / Zacks.com - Paid Partner Content
2 Top Biotech Stocks to Buy in October
Oct 18 / MotleyFool.com - Paid Partner Content
Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know
Oct 21 / Zacks.com - Paid Partner Content
Bristol Myers Squibb (BMY) Outpaces Stock Market Gains: What You Should Know
Oct 15 / Zacks.com - Paid Partner Content
TFG Advisers LLC Buys Invesco S&P 500 Equal Weight Consumer Staples ETF, SPDR Blackstone ...
Oct 21 / GuruFocus News - Paid Partner Content
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Oct 15 / Zacks.com - Paid Partner Content
Valley Brook Capital Group, Inc. Buys Bristol-Myers Squibb Co, II-VI Inc, Sells Alibaba Group ...
Oct 21 / GuruFocus News - Paid Partner Content
Prothena (PRTA) Riding High on Alzheimer's Disease Pipeline
Oct 15 / Zacks.com - Paid Partner Content
Roche's (RHHBY) Tecentriq Gets FDA Nod for Another Indication (Revised)
Oct 21 / Zacks.com - Paid Partner Content
Clovis (CLVS) Focuses on Rubraca Growth Amid Rising Competition
Oct 15 / Zacks.com - Paid Partner Content
Stewart & Patten Co Llc Buys Broadcom Inc, Danaher Corp, Sells General Electric Co, ...
Oct 20 / GuruFocus News - Paid Partner Content
3 Highly Profitable Stocks Wall Street Thinks Will Soar 39% or More
Oct 15 / MotleyFool.com - Paid Partner Content
Bristol Myers Squibb (BMY) Reports Next Week: Wall Street Expects Earnings Growth
Oct 20 / Zacks.com - Paid Partner Content
Exelixis (EXEL) Well Poised on Label Expansions of Caboemtyx
Oct 14 / Zacks.com - Paid Partner Content
Could This Beaten-Down Biotech Stock Be the Next Buyout Target?
Oct 20 / MotleyFool.com - Paid Partner Content
Epizyme's (EPZM) Tazverik Aids Growth, Overdependence a Woe
Oct 14 / Zacks.com - Paid Partner Content
Garnet Equity Capital Holdings, Inc. Buys ProShares UltraShort S&P500, DigitalBridge Group ...
Oct 19 / GuruFocus News - Paid Partner Content
Bristol Myers Squibb (BMY) Gains But Lags Market: What You Should Know
Oct 13 / Zacks.com - Paid Partner Content
McGuire Investment Group, LLC Buys Global X Genomics & Biotechnology ETF, Bristol-Myers ...
Oct 19 / GuruFocus News - Paid Partner Content
Incyte's (INCY) Going Gets Rough Despite Recent Approvals
Oct 13 / Zacks.com - Paid Partner Content
Axiom Investment Management LLC Buys Bristol-Myers Squibb Co, GlaxoSmithKline PLC, ProShares ...
Oct 18 / GuruFocus News - Paid Partner Content
bluebird (BLUE) Gives Details on Oncology Business Spinoff
Oct 12 / Zacks.com - Paid Partner Content
Why Infinity Pharmaceuticals Shot Nearly 4% Higher Today
Oct 18 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: NextEra Energy, Raytheon, Bristol-Myers Squibb, Williams Companies and Occidental Petroleum
Oct 12 / Zacks.com - Paid Partner Content
Sterneck Capital Management, LLC Buys Wells Fargo, Dimensional World ex U.S. ...
Oct 18 / GuruFocus News - Paid Partner Content
Top Stock Reports for NextEra, Raytheon & Bristol-Myers
Oct 11 / Zacks.com - Paid Partner Content
Roche's (RHHBY) Tecentriq Gets FDA Nod for Another Indication
Oct 18 / Zacks.com - Paid Partner Content
3 Top Warren Buffett Stocks to Buy in October
Oct 10 / MotleyFool.com - Paid Partner Content